…supported by SPT Labtech. From human B cells to engineered antibodies, IgGenix is taking a novel approach towards breaking through the last frontier of immunology: allergies. By reengineering key antibodies…

…will be supported by Berkeley Lights. Opto B Discovery on the Beacon optofluidic system is designed to enable rapid selection of lead candidates by function-forward screening of B cells in…

From human B cells to engineered antibodies, IgGenix is taking a novel approach towards breaking through the last frontier of immunology: allergies. By reengineering key antibodies in the allergic cascade,…

Opto B Discovery on the Beacon optofluidic system is designed to enable rapid selection of lead candidates by function-forward screening of B cells in under one week. This presentation will…

…reducing hypoxia, and turning the tumour microenvironment (TME) from immunosuppressive to immunostimulatory. These changes led to improvements in both immune system response and the effectiveness of certain anti-cancer therapies. Oliver…

…tumour cells and engaged the innate immune system by inducing type I interferon. The innate immune response modified the tumour microenvironment, counteracting suppressive forces that otherwise would tamp down T-cell…

…blood serum from cancer patients is elevated, and the conclusion is that cancer cells need more copper than healthy cells. Higher levels of copper also mean more active copper-binding proteins….

…options and reducing the overall morbidity of chronic GVHD in our transplant recipients,” said Prof Corey Cutler, Medical Director of the Stem Cell Transplantation Program at Boston’s Dana Farber Cancer…

…infrastructure that your organisation may not have. What if you could receive ready-to-use CRISPR-edited cells without needing to handle, optimise, and transfect your CRISPR library?   Register for free here….

…provide contrast, but those can be toxic and interfere with the cells and the very processes we are investigating. The questions arose: ‘What signals can we extract from cells, molecules,…